DAM
Doheny Asset Management Portfolio holdings
AUM
$143M
This Quarter Return
-2.05%
1 Year Return
+18.72%
3 Year Return
+131.17%
5 Year Return
–
10 Year Return
–
AUM
$190M
AUM Growth
+$190M
(-11%)
Cap. Flow
-$15.5M
Cap. Flow
% of AUM
-8.11%
Top 10 Holdings %
Top 10 Hldgs %
38.37%
Holding
113
New
5
Increased
14
Reduced
53
Closed
10
Top Buys
| 1 |
Karyopharm Therapeutics
KPTI
|
$3.07M |
| 2 |
AIMT
Aimmune Therapeutics, Inc.
AIMT
|
$2.64M |
| 3 |
FibroGen
FGEN
|
$1.98M |
| 4 |
Halozyme
HALO
|
$1.08M |
| 5 |
Gilead Sciences
GILD
|
$848K |
Top Sells
| 1 |
Energous
WATT
|
$3.46M |
| 2 |
Wells Fargo
WFC
|
$3.25M |
| 3 |
Exact Sciences
EXAS
|
$2.35M |
| 4 |
Great Lakes Dredge & Dock
GLDD
|
$1.8M |
| 5 |
SNR
NEW SENIOR INVESTMENT GROUP INC.
SNR
|
$1.34M |
Sector Composition
| 1 | Technology | 23.24% |
| 2 | Healthcare | 15.3% |
| 3 | Financials | 12.79% |
| 4 | Energy | 12.07% |
| 5 | Real Estate | 11.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$3.45T
| $13.6M | 7.13% | 80,994 -6,230 | -7% | -$1.05M |
|
2
BGC Group
BGC
$4.65B
| $9.46M | 4.96% | 703,050 +40,333 | +6% | +$542K |
|
3
Rithm Capital
RITM
$6.57B
| $9.45M | 4.96% | 574,150 -26,650 | -4% | -$438K |
|
|
4
Energous
WATT
$10.9M
| $8.57M | 4.5% | 534,725 -216,050 | -29% | -$3.46M |
|
5
Microchip Technology
MCHP
$35.1B
| $7.14M | 3.75% | 78,135 -8,700 | -10% | -$795K |
|
6
Bank of America
BAC
$376B
| $5.55M | 2.91% | 184,965 +23,695 | +15% | +$711K |
|
7
Johnson & Johnson
JNJ
$427B
| $5.07M | 2.66% | 39,583 -2,240 | -5% | -$287K |
|
8
SFL Corp
SFL
$1.08B
| $5.03M | 2.64% | 351,484 -42,100 | -11% | -$602K |
|
9
LXP Industrial Trust
LXP
$2.69B
| $4.9M | 2.57% | 621,950 -47,000 | -7% | -$370K |
|
10
Marathon Petroleum
MPC
$54.6B
| $4.35M | 2.29% | 59,550 -2,000 | -3% | -$146K |
|
11
Starbucks
SBUX
$100B
| $4.25M | 2.23% | 73,440 +500 | +0.7% | +$28.9K |
|
12
BP
BP
$90.8B
| $4.2M | 2.21% | 103,700 -10,200 | -9% | -$414K |
|
13
Alphabet (Google) Class C
GOOG
$2.58T
| $4.11M | 2.16% | 3,982 -675 | -14% | -$697K |
|
|
14
FibroGen
FGEN
$47.8M
| $3.86M | 2.03% | 83,510 +42,835 | +105% | +$1.98M |
|
|
15
Alphabet (Google) Class A
GOOGL
$2.57T
| $3.75M | 1.97% | 3,616 -590 | -14% | -$612K |
|
16
Phillips 66
PSX
$54B
| $3.56M | 1.87% | 37,102 -30 | -0.1% | -$2.88K |
|
17
Check Point Software Technologies
CHKP
$20.7B
| $3.35M | 1.76% | 33,696 -4,025 | -11% | -$400K |
|
|
CMBT
18
CMB.TECH NV
CMBT
$2.5B
| $3.22M | 1.69% | 392,300 -65,250 | -14% | -$535K |
|
|
19
Halozyme
HALO
$8.56B
| $3.2M | 1.68% | 163,150 +55,350 | +51% | +$1.08M |
|
|
20
Karyopharm Therapeutics
KPTI
$61.7M
| $3.07M | 1.61% | +228,990 | New | +$3.07M |
|
21
Merck
MRK
$210B
| $2.88M | 1.51% | 52,795 -1,540 | -3% | -$83.9K |
|
|
22
Gilead Sciences
GILD
$140B
| $2.64M | 1.39% | 35,006 +11,255 | +47% | +$848K |
|
|
AIMT
23
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $2.64M | 1.38% | +82,800 | New | +$2.64M |
|
|
SRLP
24
DELISTED
SPRAGUE RESOURCES LP
SRLP
| $2.55M | 1.34% | 106,850 -51,700 | -33% | -$1.23M |
|
25
Charles Schwab
SCHW
$174B
| $2.5M | 1.31% | 47,900 -5,100 | -10% | -$266K |
|